Inventor · disambiguated record
Romain Najman
Also filed as: NAJMAN ROMAIN
30 granted patents·6 pending applications·167 citations·filing 2010–2024
96Inventor score
Top patents by PatentIndex Score
36 records- 0196US9145367B2Compounds useful for treating AIDSTAZI JAMAL·Filed 2010·Granted Sep 29, 2015·51 cites·18 claims
- 0295US10981874B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2019·Granted Apr 20, 2021·5 cites·22 claims
- 0394US10683284B2Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2018·Granted Jun 16, 2020·7 cites·10 claims
- 0494US10253020B2Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature agingABIVAX·Filed 2017·Granted Apr 9, 2019·8 cites·13 claims
- 0593US9637475B2Compounds for treating cancerABIVAX·Filed 2015·Granted May 2, 2017·13 cites·27 claims
- 0692US10017498B2Compounds useful for treating AIDSABIVAX·Filed 2015·Granted Jul 10, 2018·9 cites·18 claims
- 0790US10435370B2Quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2015·Granted Oct 8, 2019·11 cites·22 claims
- 0890US9108919B2Compounds useful for treating cancerCT NATIONALE DE RECH SCIENT·Filed 2013·Granted Aug 18, 2015·18 cites·10 claims
- 0989US9061999B2Compounds useful for treating AIDSTAZI JAMAL·Filed 2011·Granted Jun 23, 2015·17 cites·14 claims
- 1088US10718770B2Methods for screening compounds for treating or preventing a viral infection or a virus-related conditionABIVAX·Filed 2016·Granted Jul 21, 2020·4 cites·24 claims
- 1186US11649211B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2020·Granted May 16, 2023·1 cites·16 claims
- 1286US9827237B2Compounds useful for treating diseases caused by retrovirusesABIVAX·Filed 2014·Granted Nov 28, 2017·10 cites·12 claims
- 1386US2025100971A1In vitro or ex vivo methods for screening a quinoline derivativeABIVAX·Filed 2024·Application pending·0 cites
- 1483US9969715B2Compounds useful for treating cancerABIVAX·Filed 2013·Granted May 15, 2018·5 cites·8 claims
- 1582US12479802B2Phenyl-n-quinoline derivatives for treating a RNA virus infectionABIVAX·Filed 2024·Granted Nov 25, 2025·0 cites·7 claims
- 1679US12084422B2Phenyl-n-quinoline derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Sep 10, 2024·1 cites·12 claims
- 1779US10717724B2Compounds useful for treating cancerABIVAX·Filed 2018·Granted Jul 21, 2020·1 cites·15 claims
- 1878US11441181B2miRNA-124 as a biomarkerABIVAX·Filed 2014·Granted Sep 13, 2022·1 cites·14 claims
- 1974US11649210B2Use of quinoline derivatives for the treatment of inflammatory diseasesABIVAX·Filed 2020·Granted May 16, 2023·0 cites·17 claims
- 2074US2024343716A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2024·Application pending·0 cites
- 2172US10975063B2Compound, and production method thereof, and methods of treatment using the compoundABIVAX·Filed 2019·Granted Apr 13, 2021·0 cites·18 claims
- 2272US9908869B2Compounds useful for treating aidsSOC SPLICOS·Filed 2014·Granted Mar 6, 2018·2 cites·25 claims
- 2369US9890112B2Compounds for use as therapeutic agents affecting p53 expression and/or activitySCHERRER DIDIER·Filed 2012·Granted Feb 13, 2018·2 cites·11 claims
- 2468US10329317B2Quinoline derivative for use in the treatment and prevention of viral infectionsABIVAX·Filed 2016·Granted Jun 25, 2019·1 cites·10 claims
- 2567US11014918B2Compounds and pharmaceutical compositions containing at least one of the compoundsABIVAX·Filed 2020·Granted May 25, 2021·0 cites·10 claims
- 2666US12247018B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 2765US12421206B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Sep 23, 2025·0 cites·17 claims
- 2863US11427566B2Compounds useful for treating cancerABIVAX·Filed 2020·Granted Aug 30, 2022·0 cites·16 claims
- 2963US2022127253A1Compounds for preventing, inhibiting, or treating cancer, aids and/or premature agingABIVAX·Filed 2021·Application pending·0 cites
- 3061US11739073B2Aryl-n-aryl derivatives for treating a RNA virus infectionABIVAX·Filed 2019·Granted Aug 29, 2023·0 cites·21 claims
- 3156US10538485B2Compounds for use as therapeutic agents affecting P53 expression and/or activityABIVAX·Filed 2017·Granted Jan 21, 2020·0 cites·11 claims
- 3251US2024182422A1Preparation method of quinoline derivative compoundsABIVAX·Filed 2022·Application pending·0 cites
- 3350US2023106420A1Aryl-n-aryl derivatives for treating a rna virus infectionABIVAX·Filed 2020·Application pending·0 cites
- 3449US9556489B2Use of RBM39 as a biomakerABIVAX·Filed 2013·Granted Jan 31, 2017·0 cites·16 claims
- 3541US10806729B2Quinoline derivatives for use in the treatment or prevention of viral infectionABIVAX·Filed 2016·Granted Oct 20, 2020·0 cites·15 claims
- 3635US2017197938A1A quinoline derivative for the treatment of inflammatory diseases and aidsABIVAX·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Romain Najman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →